Eradicating H. pylori may reduce stomach cancer risk

the ONA take:

The heliobacter pylori bacterium is the main cause of stomach ulcers, and it also a known risk factor for non-cardia gastric cancer.

A new meta-analysis published in the Cochrane Library suggests that eradicating heliobacter pylori with a short course of antibiotics may reduce the risk for developing gastric cancer.

For the systematic review, researchers identified six studies that included a total of almost 6,500 patients. Patients were typically treated with a combination of antibiotics and proton pump inhibitors to eliminate the bacteria from the body.

Results showed that 1 to 2 weeks of antibiotic plus proton pump inhibitor therapy decreased the risk for developing stomach cancer compared with placebo or no treatment at all.

Specifically, 1.6% of those who received combination therapy developed gastric cancer versus 2.4% of those who received placebo or no treatment. The authors note that the study was not able to determine whether heliobacter pylori eradication improved survival.

According to the American Cancer Society, the decline of stomach cancer incidence over the last few decades may be due to the frequent use of antibiotics to treat infections.

About 70% of Americans with history of heart disease, stroke take aspirin
The heliobacter pylori bacterium is the main cause of stomach ulcers, and it also a known risk factor for non-cardia gastric cancer.
A new review published in the Cochrane Library indicates that eradicating Helicobacter pylori bacterium- the main cause of stomach ulcers - with a short course of therapy comprising two commonly used medicines may help to reduce the risk of gastric cancer.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs